Holen Sie sich die Stockscreener-App
296.41
0.44%
1.31
Handel nachbörslich:
296.41
Charles River Laboratories International Inc Aktie (CRL) Neueste Nachrichten
What Does Charles River Laboratories International (CRL) Gain From This Vaccine Collaboration? - simplywall.st
Why Is Charles River Laboratories International (CRL) Pushing Deeper Into Vaccine Development? - Yahoo Finance
CRL Jumps 33.3% in the Past Month: Can This Strong Rally Keep Running? - TradingView
Charles River Labs stock holds near fresh 52-week high after strong Q2 earnings - Ad-hoc-news.de
Are Options Traders Betting on a Big Move in Charles River Stock? - TradingView
Charles River Gains 88.6% in a Year: What's Driving the Rally? - Yahoo Finance
Madison Asset Management LLC Invests $3.81 Million in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Labs CEO Birgit Girshick Gifts 528 Shares, Retains Significant Ownership - Kalkine Media
Charles River Laboratories Director Nancy C. Andrews Reports Form 4 Filing on Stock Option Exercise and Sale - Kalkine Media
Charles River Labs CEVP Parisotto sells $599,710 in shares By Investing.com - Investing.com Australia
Charles River Laboratories International (NYSE:CRL) Director Nancy Andrews Sells 573 Shares - MarketBeat
Charles River (NYSE: CRL) CEO makes 528-share gift of common stock - Stock Titan
Shannon Parisotto Sells 2,039 Shares of Charles River Laboratories International (NYSE:CRL) Stock - MarketBeat
Charles River Labs CEVP Parisotto sells $599,710 in shares - Investing.com
Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing - marketscreener.com
Charles River (NYSE: CRL) insider sells 2,039 shares in 10b5-1 plan - Stock Titan
Charles River (NYSE: CRL) director exercises options, sells 573 shares - Stock Titan
Charles River Labs stock hits fresh 52-week high as Medigen vaccine deal boosts sentiment - Ad-hoc-news.de
Charles River Laboratories stock hits 52-week high at $294.68 By Investing.com - Investing.com Nigeria
Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing - BioSpace
Charles River Laboratories International, Inc. and Medigen Vaccine Biologics Corp. Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing - marketscreener.com
MEX:CRL EV-to-OCF: 27.30 — 36% Above Median - GuruFocus
Is Charles River Laboratories International Inc (CRL) Overvalued - GuruFocus
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch
Charles River (NYSE: CRL) officer to sell 2,039 shares after option exercise - Stock Titan
Charles (CRL) Snapshot: Moves 4.77% Up to $292.52 in the Latest Session; Levels: the $277.89 to $307.15 Range Remains in FocusMotive Wave - Vinanet
Charles (CRL) Results Versus Estimates: Profit Per Share Surpasses Its Benchmark at the Close; Trading Move - Vinanet
Charles River Laboratories International (CRL) Cut 2026 Guidance, Is The Stock Still 11% Undervalued? - simplywall.st
Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Charles River Labs stock reaches new 12-month high as 2026 guidance lifts expectations - Ad-hoc-news.de
Charles River (NYSE: CRL) investor to sell 573 shares via UBS - Stock Titan
Resilient Charles River Labs stock hits new 12-month high as Q2 revenue tops $1 billion - AD HOC NEWS
Charles River Laboratories International (NYSE:CRL) Reaches New 12-Month HighHere's Why - MarketBeat
Birgit Girshick maps out Charles River's post-divestiture future: re-accelerating growth and a lighter portfolio - The Pharma Letter
CRL Q2 2026 Earnings: EPS Surge of 9.23% Beats Estimates as Shares Nudge LowerEarnings Volatility Report - Vinanet
What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing? - Moomoo
Handelsbanken Fonder AB Increases Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Lowered 2026 EPS Outlook and Rebounding Demand Could Be A Game Changer For Charles River (CRL) - simplywall.st
If You Invested $100 In Charles River Stock 15 Years Ago, You Would Have This Much Today - Benzinga
Birgit Girshick Sells 6,500 Shares of Charles River Laboratories International (NYSE:CRL) Stock - MarketBeat
Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Charles River Labs (CRL) CEO exercises 6,500 options and sells shares under 10b5-1 plan - Stock Titan
Charles River (CRL) executive Parisotto exercises options, sells 3,714 shares under 10b5-1 plan - Stock Titan
Invesco reports 2.98M-share stake in Charles River Laboratories (CRL) - Stock Titan
Charles River Laboratories stock hits 52-week high at $285.13 - Investing.com
Charles River Laboratories stock hits 52-week high at $285.13 By Investing.com - Investing.com Australia
Charles River Laboratories (CRL) Q2 2026 Earnings Call Transcript - The Globe and Mail
Charles River Laboratories International, Inc. $CRL Shares Sold by Pacer Advisors Inc. - MarketBeat
Insider Selling: Charles River Laboratories International (NYSE:CRL) Director Sells $7,901,575.00 in Stock - MarketBeat
Charles River Laboratories (CRL) EVP LaPlume reports bona fide gift of 257 shares - Stock Titan
Charles River (CRL) director James C. Foster exercises options and sells 28,733 shares - Stock Titan
CRL (CRL) shareholder files to sell 3,714 shares under Rule 144 - Stock Titan
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing (Aug 11, 2026) - Stock Titan
Charles River Labs SVP Michael Knell sells $1.73m in stock - Investing.com UK
Charles River Laboratories International (NYSE:CRL) Sets New 52-Week HighStill a Buy? - MarketBeat
Assenagon Asset Management S.A. Has $14.02 Million Stake in Charles River Laboratories International, Inc. $CRL - MarketBeat
0.24%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):